← Evidence map

ArticleWorld journal of gastrointestinal pharmacology and therapeutics2025

Safety and efficacy of efruxifermin in metabolic dysfunction-associated steatohepatitis: A systematic review.

Abul Bashar Mohammad Kamrul-Hasan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

4 papers cite it

2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 40937291